Novo Nordisk profit up 18 per cent – share takes a hit
Wednesday brought half-year accounts from two of Denmark’s most well-run and respected companies, Novo Nordisk and Maersk. For Novo Nordisk, operating profit grew by 18 percent compared to the first half of 2023. In the second quarter alone, sales have grown by 25 percent to DKK 68 billion. Ozempic and Wegovy drive growth The sale […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Yearly subscription
79
DKK/month.
(Billed once a year)
The post Novo Nordisk profit up 18 per cent – share takes a hit appeared first on The Copenhagen Post.